Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

NCT00704678 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: SBR759
DRUG: Sevelamer HCl
DRUG: Sevelamer HCl
DRUG: Sevelamer HCl

Sponsor

Novartis Pharmaceuticals